Close

OncoCyte (OCX) Announces Ronald Andrews will assume Role of CEO

June 6, 2019 6:32 AM EDT Send to a Friend
OncoCyte Corporation (NYSE: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, today announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login